Publications
Understanding the preferences of people with acute leukemia for different health outcomes
25 September 2025
When we want to understand or measure someone’s “health-related…
Taking STRIDES: The value of diagnostics against AMR
10 June 2025
Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance…
Altering the trajectory of HIV in Europe
22 May 2025
Despite substantial medical advancements that have transformed HIV into a…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
Long-acting (LA) therapies represent a significant innovation in pharmaceutical…
Insights
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
The following is an extract from OHE’s written submission to parliament…
Environmental sustainability in the NHS 10 Year Health Plan: The need for green
29 September 2025
This is the second in a series of blogs about how the proposals in the recently…
Around the World in HTAs: Saudi Arabia – Navigating the healthcare and HTA landscape
24 September 2025
The next stop in our around the world in HTAs adventure is Saudi Arabia. This…
The true cost and burden of frontotemporal dementia: Early insights into a pressing challenge
22 September 2025
In recognition of Frontotemporal Dementia Awareness Week, OHE shares ongoing…
Robust analysis, real-world problems
OHE research supports pragmatic solutions and stronger policy decisions
Areas of expertise
OHE’s expertise covers a wide range of topics
Health Technology Assessment (HTA)
Around the World in HTAs: Saudi Arabia – Navigating the healthcare and HTA landscape
The next stop in our around the world in HTAs adventure is Saudi Arabia. This blog breaks down how the Kingdom is reshaping…
Around the world in HTAs: China – From fragmentation to function
In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Meng Li, Claud…
Drug Development/R&D
OHE’s submission to a parliamentary inquiry on UK drug shortages
The following is an extract from OHE’s written submission to parliament focused on diversifying suppliers and recognising…
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
This is the second in our series of Insights considering the implications of President Trump’s Executive Order on ‘Most…
Digital Health
The true cost and burden of frontotemporal dementia: Early insights into a pressing challenge
In recognition of Frontotemporal Dementia Awareness Week, OHE shares ongoing work quantifying the disease burden and…
OHE’s submission for the DHSC’s next 10 years of planning
This Insight summarises the recommendations OHE submitted towards the Department of Health & Social Care’s consultation…
Prevention
Prevention in the NHS 10 Year Health Plan: Promise, limits, and the path forward
This is the first in a series of blogs about how the proposals in the newly published 10 Year Plan measure up against some…
Climate action is health action: OHE’s focus on sustainability
At the intersection of health and the climate is an urgent crisis. This crisis affects health in ways that are…